Bedrijfsoverzicht
Upexi, Inc. is a specialized entity focused on the development, manufacture, and distribution of a diverse array of consumer products, ranging from pet supplements and nail grinders to energy solutions and cannabinoid formulations. The company operates within the Communication Services sector, specifically classified under the Internet Content & Information industry, which positions it as a digital-native brand aggregator despite its physical product portfolio. The organization employs 59 individuals and maintains a market capitalization of $76.28M, while reporting a trailing twelve-month (TTM) revenue of $24.74M. These financial metrics indicate that Upexi is a small-cap enterprise with a relatively modest revenue base compared to established conglomerates, suggesting a position in the early-to-mid growth phase where market penetration is critical for scaling operations.
Financiële gezondheid
The company reported a TTM revenue of $24.74M against a net income loss of $-122,934,128, a significant discrepancy that reveals a highly volatile or heavily subsidized cost structure where expenses drastically exceed earnings before tax adjustments. The reported EBITDA stands at $-114,581,064, indicating that even before interest, taxes, depreciation, and amortization, the core business operations are currently generating negative cash value. Free cash flow is negative at $-216,210,592, which implies a lack of immediate financial flexibility to fund internal expansion or debt service without external capital injections. Margins reflect this financial strain, with a gross margin of 80.7% showing efficient production costs, but an operating margin of -2160.2% and a profit margin of 0.0% signaling severe operational inefficiencies or substantial non-operating losses. The balance sheet is highly leveraged, holding $1.62M in cash against $213.48M in debt, resulting in a debt-to-equity ratio of 438.20. Despite the high leverage, the current ratio of 2.20 suggests the company maintains adequate short-term liquidity to cover immediate obligations. Return on Equity is negative at -468.5% and return on assets is -49.9%, metrics that reveal management is currently destroying shareholder value rather than generating returns on the capital deployed.
Waarderingsbeoordeling
Valuation multiples for Upexi present a complex picture, with a trailing P/E ratio of N/A due to the lack of positive net income, while the forward P/E is listed at -3.86, implying analysts project continued losses in the near term. The price-to-book ratio is 1.42, indicating the market values the company at a 42% premium over its net asset book value, which is unusual for a firm with negative earnings. The price-to-sales ratio stands at 3.08, suggesting investors are willing to pay more than three times the annual revenue for a company with significant losses, while the EV/EBITDA multiple of -2.52 further underscores the reliance on alternative valuation methods for loss-making entities. Historical price volatility is evident with a 52-week high of $22.57 and a 52-week low of $0.54, meaning the current trading environment has experienced extreme fluctuations relative to this wide range. The beta of -0.59 indicates a negative correlation to the broader market, suggesting the stock price tends to move inversely to market indices, which adds a unique layer of volatility and risk for investors tracking the overall market performance.
Growth & Income
Revenue growth is robust at 101.0% year-over-year, demonstrating a rapid expansion in sales volume, whereas earnings growth is N/A because the company has not yet achieved profitability. Since earnings growth cannot be calculated against revenue when net income is negative, the implication is that top-line scaling is occurring without immediate bottom-line improvement, a common characteristic in early-stage consumer product businesses. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which confirms that all available cash flow is reinvested into growth initiatives rather than distributed to shareholders. The overall growth and income profile characterizes Upexi as a high-risk, high-potential expansion play that prioritizes market share acquisition and product diversification over current income generation or shareholder returns.